Sign Out
Pregnant Women: There are no EPLERENONA PENTAFARMA TABLETS studies in pregnant women. Eplerenone did not impair fertility and was not teratogenic in animals but the risk to the fetus of pregnant women is not known. Therefore, EPLERENONA PENTAFARMA TABLETS should be used during pregnancy only if the potential benefit to the mother justifies the potential risk to the fetus.
Nursing Women: It has not been determined if EPLERENONA PENTAFARMA TABLETS is present in human breast milk, however it was present in rat breast milk at a milk to plasma ratio of 0.85. Because many drugs are excreted in human milk and because of the unknown potential for adverse effects on the nursing infant, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
